| DC Field | Value | Language |
|---|
| dc.contributor.author | Abdikadirova T.Sh., Nasirova H.K., Trigulova R.X. | - |
| dc.date.accessioned | 2026-09-16T10:57:33Z | - |
| dc.date.available | 2026-09-16T10:57:33Z | - |
| dc.date.issued | 2023-09 | - |
| dc.identifier.issn | 2181-3337 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/5210 | - |
| dc.description.abstract | This review presents various perspectives of scientists regarding the effectiveness
of Amiodarone as a preferred antiarrhythmic drug commonly used for the treatment of ventricular
arrhythmias and atrial fibrillation (AF). However, due to the high toxicity of Amiodarone, there
is a risk of potential damage to various organs, including the liver, lungs, cornea, skin, and thyroid
gland. According to the scientific literature, the most commonly observed disorders associated
with Amiodarone use are subclinical hypothyroidism (18%) and overt thyrotoxicosis (15.8%), with
less frequent occurrences of overt hypothyroidism (1.5%) and subclinical thyrotoxicosis (1.5%).
Continuous research in this field has led to a change in the understanding of the problem and the
development of new approaches to the diagnosis and treatment of these disorders | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | O'zbekiston, Toshkent (SCIENCE AND INNOVATION) International Scientific Journal | en_US |
| dc.subject | Amiodarone, arrhythmia, Amiodarone-induced thyrotoxicosis, Amiodarone induced hypothyroidism. | en_US |
| dc.title | MODERN VIEWS ON THE PROBLEM OF AMIODARONE-INDUCED THYROID DYSFUNCTION | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
